Results 191 to 200 of about 7,196 (266)

Direct tumour–adipocyte contact / Stroma AReactive Invasion Front Area (TAC/SARIFA) predicts adverse outcome in colorectal cancer: a focused evidence synthesis and meta‐analysis

open access: yesHistopathology, Volume 89, Issue 5, Page 835-848, November 2026.
TAC/SARIFA, defined by direct tumour–adipocyte contact at the invasion front, represents a reproducible, biologically meaningful H&E biomarker with consistent adverse prognostic associations in CRC. Aims Direct tumour‐adipocyte interaction at the invasion front, termed Stroma AReactive Invasion Front Areas (SARIFA), has recently emerged as a novel H&E ...
Nic G Reitsam   +3 more
wiley   +1 more source

Taste-masked tilmicosin-loaded nanostructured lipid carriers at pilot scale for improved bioavailability and enhanced efficacy against <i>Salmonella</i> infection in swine. [PDF]

open access: yesInt J Pharm X
Gong J   +14 more
europepmc   +1 more source

OsYchF1 suppresses OsEF1Bγ‐mediated ER detoxification to co‐involve the growth‐maintenance trade‐off in rice

open access: yesThe Plant Journal, Volume 128, Issue 3, November 2026.
SUMMARY Translation elongation is a fundamental biological process, yet its direct role in stress adaptation remains unclear. In this study, we uncover a novel regulatory axis in rice involving the unconventional G protein OsYchF1, which gates the detoxification activity of the elongation factor 1Bγ (OsEF1Bγ) in the endoplasmic reticulum.
Liyang Gao   +10 more
wiley   +1 more source

Effect of Piperine Codelivery on the Oral Bioavailability of Cannabidiol: Insights from <i>In Vitro</i> Digestion and <i>In Vivo</i> Pharmacokinetics. [PDF]

open access: yesJ Agric Food Chem
Vardanega R   +8 more
europepmc   +1 more source

Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment - An <i>in vivo</i> study. [PDF]

open access: yesBioimpacts
Heydari S   +6 more
europepmc   +1 more source

Nanostructured lipid carriers as co-delivery systems for cancer therapy: Prospects and challenges. [PDF]

open access: yesInt J Pharm X
Hidayat AF   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy